A COMPARATIVE-STUDY OF CAPTOPRIL AND ENALAPRIL IN PATIENTS WITH SEVERE HYPERTENSION

被引：16
作者：
CHRYSANT, SG
BAL, IS
JOHNSON, B
MCPHERSON, M
机构：
[1] OKLAHOMA CARDIOVAS & HYPERTENS CTR, 1505 N ROCKWELL AVE, OKLAHOMA CITY, OK 73127 USA
[2] VET ADM MED CTR, HYPERTENS SECT, KANSAS CITY, MO 64128 USA
[3] UNIV KANSAS, MED CTR, KANSAS CITY, KS 66103 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 25卷 / 02期
关键词：
D O I：
10.1002/j.1552-4604.1985.tb02816.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：149 / 151
页数：3
相关论文
共 15 条
[1]  
AMANN FW, 1980, LANCET, V1, P150
[2]   CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].
CASE, DB ;
ATLAS, SA ;
LARAGH, JH ;
SEALEY, JE ;
SULLIVAN, PA ;
MCKINSTRY, DN .
PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206
[3]   PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPY [J].
CASE, DB ;
ATLAS, SA ;
MOURADIAN, JA ;
FISHMAN, RA ;
SHERMAN, RL ;
LARAGH, JH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04) :346-349
[4]   RACIAL-DIFFERENCES IN PRESSURE, VOLUME AND RENIN INTERRELATIONSHIPS IN ESSENTIAL HYPERTENSION [J].
CHRYSANT, SG ;
DANISA, K ;
KEM, DC ;
DILLARD, BL ;
SMITH, WJ ;
FROHLICH, ED .
HYPERTENSION, 1979, 1 (02) :136-141
[5]   ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].
CHRYSANT, SG ;
BROWN, RD ;
KEM, DC ;
BROWN, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746
[6]   SEVERE REVERSIBLE AZOTEMIA FROM CAPTOPRIL THERAPY - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE [J].
CHRYSANT, SG ;
DUNN, M ;
MARPLES, D ;
DEMASTERS, K .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) :437-441
[7]  
CHRYSANT SG, 1983, CURRENT THERAPEUTIC, V43, P857
[8]   A COMPARATIVE PILOT-STUDY OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION [J].
FERGUSON, RK ;
VLASSES, PH ;
IRVIN, JD ;
SWANSON, BN ;
LEE, RB .
JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (07) :281-289
[9]  
GAVRAS H, 1981, LANCET, V2, P543
[10]   ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].
GAVRAS, H ;
BRUNNER, HR ;
TURINI, GA ;
KERSHAW, GR ;
TIFFT, CP ;
CUTTELOD, S ;
GAVRAS, I ;
VUKOVICH, RA ;
MCKINSTRY, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995
12